NCT03579173

Brief Summary

The overall objective of this study is to determine the impact early nutritional and respiratory indices have on early CF lung disease. This knowledge will guide clinical management of infants with CF, who are now primarily diagnosed through newborn screening.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 8, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 25, 2018

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 6, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 6, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 6, 2019

Completed
Last Updated

June 22, 2022

Status Verified

June 1, 2022

Enrollment Period

9 months

First QC Date

June 25, 2018

Last Update Submit

June 16, 2022

Conditions

Keywords

Nutritional StatusInfant Pulmonary Function TestingLung Clearance IndexMultiple Breath Washout

Outcome Measures

Primary Outcomes (1)

  • Lung function

    Forced expiratory volume in 0.5 seconds

    24 months

Secondary Outcomes (2)

  • Lung function - FRC

    24 months

  • Lung function - MBW

    24 months

Study Arms (3)

Nutrition and Infant PFT

To examine the relationship between nutritional status (weight-for-age (WFA) and weight-for-length (WFL)) at 6 months of age and lung function at 1-2 years of age in infants with CF.

Diagnostic Test: Infant PFT

Nutrition and Lung Clearance Index

To examine the relationship between nutritional status (WFA and WFL) in infants with CF at 12 months of age and the lung clearance index (LCI) at 3-5 years of age.

Diagnostic Test: Lung Clearance Index

Passive Tidal Breathing and Infant PFT

To delineate the relationship between passive tidal breathing lung function testing in infants with CF at 4-8 weeks of age and subsequent lung function at 6-12 months of age.

Diagnostic Test: Infant PFTDiagnostic Test: Passive tidal breathing

Interventions

Infant PFTDIAGNOSTIC_TEST

Assessed through the raised volume rapid thoracoabdominal compression technique and plethysmography

Nutrition and Infant PFTPassive Tidal Breathing and Infant PFT
Lung Clearance IndexDIAGNOSTIC_TEST

The Lung Clearance Index is derived from the Multiple Breath Washout test. It is the cumulative exhaled volume (the volume of gas needed to wash out resident gas mixture out of the lungs) divided by the FRC. The FRC is the amount of air left in the lungs after normal exhalation.

Nutrition and Lung Clearance Index

During quiet sleep, tidal breathing flow-volume curves are obtained. The tPEF/tE is calculated by taking the time it takes to reach peak expiratory flow divided by the total peak expiratory time.

Passive Tidal Breathing and Infant PFT

Eligibility Criteria

Age1 Month - 5 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Infants and preschoolers with cystic fibrosis diagnosed by newborn screen.

You may qualify if:

  • Informed consent by a parent or legal guardian
  • A confirmed diagnosis of CF by newborn screening and either a documented sweat chloride of at least 60 mEq/L by quantitative pilocarpine iontophoresis or a genotype with two CF-causing mutations
  • One month to five years of age.

You may not qualify if:

  • Chronic lung disease not due to CF
  • Contraindications to sedation, including structural abnormalities of the upper airway or chest wall and severe gastroesophageal reflux
  • Gestational age \< 36 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Riley Hospital for Children

Indianapolis, Indiana, 46202, United States

Location

Study Officials

  • Heather Muston, MD

    Indiana University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Clinical Pediatrics

Study Record Dates

First Submitted

June 25, 2018

First Posted

July 6, 2018

Study Start

May 8, 2018

Primary Completion

February 6, 2019

Study Completion

February 6, 2019

Last Updated

June 22, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

Locations